Document Detail


Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis [Review article].
MedLine Citation:
PMID:  23317949     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Exacerbations contribute substantially to the morbidity and mortality associated with chronic obstructive pulmonary disease (COPD).
OBJECTIVES: To assess whether prophylactic antibiotic treatment reduces exacerbations in patients with COPD and/or chronic bronchitis.
METHODS: Medline, EMBASE, Cochrane Central Register of Controlled Trials, Koreamed and references from relevant publications were searched up to October 2011. Randomised controlled trials comparing the effect of any prophylactic antibiotics with placebo for at least 3 months were included. The co-primary outcomes were the frequency of exacerbations of COPD or chronic bronchitis and adverse treatment events.
RESULTS: A total of 19 trials involving 3932 subjects were included in the analysis: 5 recent trials included patients with moderate to severe COPD, whereas 14 older trials included patients with chronic bronchitis. The use of antibiotics significantly reduced the rate of COPD exacerbations (risk ratio [RR] 0.73, 95%CI 0.66-0.82), the number of chronic bronchitis exacerbations (standardised mean difference -0.23, 95%CI -0.35--0.11) and the proportion of patients with exacerbations of chronic bronchitis (RR 0.93, 95%CI 0.87-0.99).
CONCLUSION: Prophylactic antibiotic treatment has a significant effect in reducing exacerbations in patients with COPD and/or chronic bronchitis.
Authors:
J S Lee; D-A Park; Y Hong; K W Jo; S W Lee; J W Huh; Y-M Oh; S-D Lee
Related Documents :
15673199 - A pentaherbs capsule as a treatment option for atopic dermatitis in children: an open-l...
9236949 - Validity and reliability of the alzheimer's disease cooperative study-clinical global i...
9876959 - A 25-week placebo-controlled study of eptastigmine in patients with alzheimer disease.
1421679 - Implications of the study population in the early evaluation of anticholinesterase inhi...
17646619 - Ideal: a 6-month, double-blind, placebo-controlled study of the first skin patch for al...
24190439 - Antibiotics for sore throat.
6860079 - Personality attributes of depressive patients.
23059159 - Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomiz...
24666019 - Emerging role of probiotics and antimicrobials in the management of irritable bowel syn...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  17     ISSN:  1815-7920     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  153-62     Citation Subset:  IM    
Affiliation:
Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes of surgery in the treatment of isolated nonnative mitral valve infective endocarditis.
Next Document:  Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study.